Journal of Molecular Medicine

, Volume 83, Issue 8, pp 587–595

Human defensins

  • Josef Johann Schneider
  • Angela Unholzer
  • Martin Schaller
  • Monika Schäfer-Korting
  • Hans Christian Korting


Antimicrobial peptides are small, cationic, amphiphilic peptides of 12–50 amino acids with microbicidal activity against both bacteria and fungi. The eukaryotic antimicrobial peptides may be divided into four distinct groups according to their structural features: cysteine-free α-helices, extended cysteine-free α-helices with a predominance of one or two amino acids, loop structures with one intramolecular disulfide bond, and β-sheet structures which are stabilised by two or three intramolecular disulfide bonds. Mammalian defensins are part of the last-mentioned group. The mammalian defensins can be subdivided into three main classes according to their structural differences: the α-defensins, β-defensins and the recently described θ-defensins. Mammalian α-defensins are predominantly found in neutrophils and in small intestinal Paneth cells, whereas mammalian β-defensins have been isolated from both leukocytes and epithelial cells. Recently, two novel human β-defensins, human beta-defensin-3 (HBD-3), and human beta-defensin-4 (HBD-4) have been discovered. Similar to HBD-1 and HBD-2, HBD-3 has microbicidal activity towards the Gram-negative bacteria (Pseudomonas aeruginosa, Escherichia coli) and the yeasts Candida albicans and Malassezia furfur. In addition, HBD-3 kills Gram-positive bacteria such as Streptococcus pyogenes or Staphylococcus aureus, including multi-resistant S. aureus strains, and even vancomycin-resistant Enterococcus faecium. In contrast to HBD-1 and HBD-2, significant expression of HBD-3 has been demonstrated in non-epithelial tissues, such as leukocytes, heart and skeletal muscle. HBD-4 is expressed in certain epithelia and in neutrophils. Its bactericidal activity against P. aeruginosa is stronger than that of the other known β-defensins. Here we present an overview of human antimicrobial peptides with some emphasis on their antifungal properties.


Antimicrobial peptides Human defensins Human neutrophil peptides HBD-3 HBD-4 


  1. 1.
    Müller F-MC, Lyman CA, Walsh TJ (1999) Antimicrobial peptides as potential new antifungals. Mycoses 42 [Suppl 2]:77–82Google Scholar
  2. 2.
    Hancock RE, Falla T, Brown M (1995) Cationic bactericidal peptides. Adv Microb Physiol 37:135–175Google Scholar
  3. 3.
    Ganz T, Lehrer RI (1994) Defensins. Curr Opin Immunol 6:584–589Google Scholar
  4. 4.
    Weinberg A, Krisanaprakornkit S, Dale BA (1998) Epithelial antimicrobial peptides: review and significance for oral applications. Crit Rev Oral Biol Med 9:399–414Google Scholar
  5. 5.
    Schröder J-M (1999) Epithelial antimicrobial peptides: innate local host response elements. Cell Mol Life Sci 56:32–46Google Scholar
  6. 6.
    Boman HG (1995) Peptide antibiotics and their role in innate immunity. Annu Rev Immunol 13:61–92Google Scholar
  7. 7.
    De Lucca AJ, Walsh TJ (1999) Antifungal peptides: novel therapeutic compounds against emerging pathogens. Antimicrob Agents Chemother 43:1–11Google Scholar
  8. 8.
    Hancock RE (1997) Peptide antibiotics. Lancet 249:418–422Google Scholar
  9. 9.
    Hancock RE, Chapple DS (1999) Peptide antibiotics. Antimicrob Agents Chemother 43:1317–1323Google Scholar
  10. 10.
    Lehrer RI, Ganz T (1999) Antimicrobial peptides in mammalian and insect host defence. Curr Opin Immunol 11:23–27Google Scholar
  11. 11.
    Schröder J-M, Harder J (1999) Human beta-defensin-2. Int J Biochem Cell Biol 31:645–651Google Scholar
  12. 12.
    Huttner KM, Bevins CL (1999) Antimicrobial peptides as mediators of epithelial host defense. Pediatr Res 45:785–794Google Scholar
  13. 13.
    Sparkes RS, Kronenberg M, Heinzmann C, Daher KA, Klisak I, Ganz T, Mohandas T (1989) Assignment of defensin genes to human chromosome 8p23. Genomics 5:240–244Google Scholar
  14. 14.
    Bevins CL, Jones DE, Dutra A, Schaffzin J, Muenke MM (1996) Human enteric defensin genes: chromosomal map position and a model of possible evolutionary relationships. Genomics 31:95–106Google Scholar
  15. 15.
    Liu L, Zhao C, Heng HH, Ganz T (1997) The human beta-defensin-1 and alpha-defensins are encoded by adjacent genes: two peptide families with differing disulfide topology share a common ancestry. Genomics 43:316–320Google Scholar
  16. 16.
    Harder J, Siebert R, Zhang Y, Matthiesen P, Christophers E, Schlegelberger B, Schroder JM (1997) Mapping of the gene encoding human beta-defensin-2 (DEFB2) to chromosome region 8p22-p 23:1. Genomics 46:472–475Google Scholar
  17. 17.
    Park CH, Valore EV, Waring AJ, Ganz T (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276:7806–7810CrossRefPubMedGoogle Scholar
  18. 18.
    Tang YQ, Yuan J, Osapay G, Osapay K, Tran D, Miller CJ, Ouellette AJ, Selsted ME (1999) A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins. Science 286:489–502Google Scholar
  19. 19.
    Ganz T (2003) Angiogenin: an antimicrobial ribonuclease. Nat Immunol 5:836–843Google Scholar
  20. 20.
    Hornef MW, Pütsep K, Karlsson J, Refai E, Andersson M (2004) Increased diversity of intestinal antimicrobial peptides by covalent dimmer formation. Nat Immunol 5:836–843Google Scholar
  21. 21.
    Zanetti M, Gennaro R, Romeo D (1995) Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett 374:1–5CrossRefPubMedGoogle Scholar
  22. 22.
    Kagan BL, Ganz T, Lehrer RI (1994) Defensins: a family of antimicrobial and cytotoxic peptides. Toxicology 87:131–149Google Scholar
  23. 23.
    Hill CP, Yee J, Selsted ME, Eisenberg D (1991) Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. Science 251:1481–1485Google Scholar
  24. 24.
    Bauer F, Schweimer K, Klüver E, Conejo-Garcia JR, Forssmann WG, Rösch P, Adermann K, Sticht H (2001) Structure determination of human and murine beta-defensins reveals structural conservation in the absence of significant sequence similarity. Protein Sci 10:2470–2479Google Scholar
  25. 25.
    Zimmermann GR, Legault P, Selsted ME, Pardi A (1995) Solution structure of bovine neutrophil beta-defensin-2: the peptide fold of the beta-defensins is identical to that of the classical defensins. Biochemistry 34:13663–13671Google Scholar
  26. 26.
    Lehrer RI, Ganz T (1992) Defensins: endogeneous antibiotic peptides from human leukocytes. Ciba Found Symp 171:276–290Google Scholar
  27. 27.
    Selsted ME, Harwig SS (1989) Determination of the disulfide array in the human defensin HNP-2: a covalently cyclized peptide. J Biol Chem 264:4003–4007Google Scholar
  28. 28.
    Skalicky JJ, Selsted ME, Pardi A (1994) Structure and dynamics of the neutrophil defensins NP-2, NP-5, and HNP-1: NMR studies of amide hydrogen exchange kinetics. Proteins 20:52–67Google Scholar
  29. 29.
    Mallow EB, Harris A, Salzman N, Russell JP, DeBerardinis JR, Ruchelli E, Bevins CL (1996) Human enteric defensins: gene structure and developmental expression. J Biol Chem 271:4038–4045Google Scholar
  30. 30.
    Ganz T, Selsted ME, Szklarek D, Harwig SS, Daher K, Bainton DF, Lehrer RI (1985) Defensins: natural peptide antibiotics of human neutrophils. J Clin Invest 76:1427–1435Google Scholar
  31. 31.
    Wilde CG, Griffith JE, Marra NN, Snable JL, Scott RW (1989) Purification and characterization of human neutrophil peptide 4, a novel member of the defensin family. J Biol Chem 264:11200–11203Google Scholar
  32. 32.
    Hristova K, Selsted ME, White SH (1996) Interactions of monomeric rabbit neutrophil defensins with bilayers: comparison with dimeric human defensin HNP-2. Biochemistry 35:11888–11894Google Scholar
  33. 33.
    Soong LB, Ganz T, Ellison A, Caughey GH (1997) Purification and characterization of defensins from cystic fibrosis sputum. Inflamm Res 46:98–102Google Scholar
  34. 34.
    Ghosh D, Porter E, Shen B, Lee SK, Wilk D, Drazba J, Yadav SP, Crabb JW, Ganz T, Bevins CL (2002) Paneth cell trypsin is the processing enzyme or human defensin-5. Nat Immunol 3:583–590Google Scholar
  35. 35.
    Salzman NH, Ghosh D, Huttner KM, Paterson Y, Bevins CL (2003) Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 422:522–526Google Scholar
  36. 36.
    Wilson CL, Ouellette AJ, Satchell DP, Ayabe T, López-Boado YS, Stratman JL, Hultgren SJ, Matrisian LM, Parks WC (1999) Regulation of intestinal α-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 286:113–117Google Scholar
  37. 37.
    Ayabe T, Satchell DP, Wilson CL, Parks WC, Selsted ME, Ouellette AJ (2000) Secretion of microbicidal α-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol 1:113–118Google Scholar
  38. 38.
    Quayle AJ, Porter E, Nussbaum AA, Wang YM, Brabec C, Yip K-P, Mok SC (1998) Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. Am J Pathol 152:1247–1258Google Scholar
  39. 39.
    Svinarich DM, Gomez R, Romero R (1997) Detection of human defensins in the placenta. Am J Reprod Immunol 38:252–255Google Scholar
  40. 40.
    Lehrer RI, Lichtenstein AK, Ganz T (1993) Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol 11:105–128Google Scholar
  41. 41.
    Daher KA, Selsted ME, Lehrer RI (1986) Direct inactivation of viruses by human granulocyte defensins. J Virol 60:1068–1074Google Scholar
  42. 42.
    Lehrer RI, Ganz T, Szklarek D, Selsted ME (1988) Modulation of the in vitro candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations. J Clin Invest 81:1829–1835Google Scholar
  43. 43.
    Couto MA, Liu L, Lehrer RI, Ganz T (1994) Inhibition of intracellular Histoplasma capsulatum replication by murine macrophages that produce human defensin. Infect Immun 62:2375–2378Google Scholar
  44. 44.
    Porter EM, Van Dam E, Valore EV, Ganz T (1997) Broad-spectrum antimicrobial activity of human intestinal defensin 5. Infect Immun 65:2396–2601Google Scholar
  45. 45.
    Tang YQ, Selsted ME (1993) Characterization of the disulfide motif in BNBD-12, an antimicrobial beta-defensin peptide from bovine neutrophils. J Biol Chem 268:6649–6653Google Scholar
  46. 46.
    Diamond G, Zasloff M, Eck H, Brasseur M, Maloy WL, Bevins CL (1991) Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA. Proc Natl Acad Sci USA 88:3952–3956Google Scholar
  47. 47.
    Schonwetter BS, Stolzenberg ED, Zasloff MA (1995) Epithelial antibiotics induced at sites of inflammation. Science 267:1645–1648PubMedGoogle Scholar
  48. 48.
    Mathews M, Jia HP, Guthmiller JM, Losh G, Graham S, Johnson GK, Tack BF, McCray PB Jr (1999) Production of β-defensin antimicrobial peptides by the oral mucosa and salivary glands. Infect Immun 67:2740–2745Google Scholar
  49. 49.
    Bensch KW, Raida M, Mägert HJ, Schulz-Knappe P, Forssmann WG (1995) hBD-1: a novel β-defensin from human plasma. FEBS Lett 368:331–335Google Scholar
  50. 50.
    Fulton C, Anderson GM, Zasloff M, Bull R, Quinn AG (1997) Expression of natural peptide antibiotics in human skin. Lancet 350:1750–1751Google Scholar
  51. 51.
    Zhao C, Wang I, Lehrer RI (1996) Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett 396:319–322Google Scholar
  52. 52.
    McCray PB Jr, Bentley L (1997) Human airway epithelia express a beta-defensin. Am J Respir Cell Mol Biol 16:343–349Google Scholar
  53. 53.
    Krisanaprakornkit S, Weinberg A, Perez CN, Dale BA (1998) Expression of the peptide antibiotic human β-defensin 1 in cultured gingival epithelial cells and gingival tissue. Infect Immun 66:4222–4228Google Scholar
  54. 54.
    Valore EV, Park CH, Quayle AJ, Wiles KR, McCray PB Jr, Ganz T (1998) Human β-defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest 101:1633–1642Google Scholar
  55. 55.
    Goldman MJ, Anderson GM, Stolzenberg ED, Kart UP, Zasloff M, Wilson JM (1997) Human β-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88:553–580Google Scholar
  56. 56.
    Knowles MR, Robinson JM, Wood RE, Pue CA, Mentz WM, Wager GC, Gatzy JT, Boucher RC (1997) Ion composition of airway surface liquid of patients with cystic fibrosis as compared with normal and disease control subjects. J Clin Invest 100:2588–2595Google Scholar
  57. 57.
    Matsui H, Grubb BR, Tarran R, Randell SH, Gatzy JT, Davis CW, Boucher RC (1998) Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 95:1005–1015Google Scholar
  58. 58.
    Harder J, Bartels J, Christophers E, Schröder J-M (1997) A peptide antibiotic from human skin. Nature 387:861Google Scholar
  59. 59.
    Bals R, Wang X, Wu Z, Freeman T, Bafna V, Zasloff M, Wilson JM (1998) Human β-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest 102:874–880Google Scholar
  60. 60.
    Hiratsuka T, Nakazato M, Date Y, Ashitani J, Minematsu T, Chino N, Matsukura S (1998) Identification of human beta-defensin-2 in respiratory tract and plasma and its increase in bacterial pneumonia. Biochem Biophys Res Commun 249:943–947Google Scholar
  61. 61.
    Chadebech P, Goidin D, Jacquet C, Viac J, Schmitt D, Staquet MJ (2003) Use of human reconstructed epidermis to analyze the regulation of beta-defensin hBD-1, hBD-2, and hBD-3 expression in response to LPS. Cell Biol Toxicol 19:313–324Google Scholar
  62. 62.
    Donnarumma G, Paoletti I, Buommino E, Orlando M, Tufano MA, Baroni A (2004) Malassezia furfur induces the expression of β-defensin-2 in human keratinocytes in a protein kinase C-dependent manner. Arch Dermatol Res 295:474–481Google Scholar
  63. 63.
    Singh PK, Jia HP, Wiles K, Hesselberth J, Liu L, Conway B-AD, Greenberg EP, Valore EV, Welsh MJ, Ganz T, Tack BF, McCray PB Jr (1998) Production of β-defensins by human airway epithelia. Proc Natl Acad Sci USA 95:14961–14966Google Scholar
  64. 64.
    Chung WO, Hansen SR, Rao D, Dale BA (2004) Protease-activated receptor signaling increases epithelial antimicrobial peptide expression. J Immunol 173:5165–5170Google Scholar
  65. 65.
    Harder J, Bartels J, Christophers E, Schröder JM (2001) Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 276:5707–5713Google Scholar
  66. 66.
    Garcia JR, Jaumann F, Schulz S, Krause A, Rodriguez-Jimenez J, Forssmann U, Adermann K, Klüver E, Vogelmeier C, Becker D, Hedrich R, Forssmann W-G, Bals R (2001) Identification of a novel, multifunctional β-defensin (hBD-3) with specific antimicrobial activity: its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res 306:257–264CrossRefPubMedGoogle Scholar
  67. 67.
    Diamond G, Kaiser V, Rhodes J, Russell JP, Bevins CL (2000) Transcriptional regulation of β-defensin gene expression in tracheal epithelial cells. Infect Immun 68:113–119Google Scholar
  68. 68.
    Jia HP, Schutte BC, Schudy A, Linzmeier R, Guthmiller JM, Johnson GK, Tack BF, Mitros JP, Rosenthal A, Ganz T, McCray PB Jr (2001) Discovery of new human beta-defensins using a genomics-based approach. Gene 263:211–218Google Scholar
  69. 69.
    Garcia JR, Krause A, Schulz S, Rodriguez-Jimenez F-J, Klüver E, Adermann K, Forssmann U, Frimpong-Boateng A, Bals R, Forssmann W-G (2001) Human β-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J 15:1819–1821Google Scholar
  70. 70.
    Peschel A, Otto M, Jack RW, Kalbacher H, Jung G, Gotz F (1999) Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem 274:8405–8410Google Scholar
  71. 71.
    Lehrer RI, Barton A, Daher K, Harwig SS, Ganz T, Selsted ME (1989) Interaction of human defensins with Escherichia coli: mechanism of bactericidal activity. J Clin Invest 84:553–561Google Scholar
  72. 72.
    Kagan BL, Selsted ME, Ganz T, Lehrer RI (1990) Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes. Proc Natl Acad Sci USA 87:210–214Google Scholar
  73. 73.
    Fujii G, Selsted ME, Eisenberg D (1993) Defensins promote fusion and lysis of negatively charged membranes. Protein Sci 2:1301–1312Google Scholar
  74. 74.
    Wimley WC, Selsted ME, White SH (1994) Interactions between human defensins and lipid bilayers: evidence for formation of multimeric pores. Protein Sci 3:1362–1373Google Scholar
  75. 75.
    Lohner K, Latal A, Lehrer RI, Ganz T (1997) Differential scanning microcalorimetry indicates that human defensin, HNP-2, interacts specifically with biomembrane mimetic systems. Biochemistry 36:1525–1531Google Scholar
  76. 76.
    Cociancich S, Ghazi A, Hetru C, Hoffmann JA, Letellier L (1993) Insect defensin, an inducible antibacterial peptide, forms voltage-dependent channels in Micrococcus luteus. J Biol Chem 268:19239–19245Google Scholar
  77. 77.
    Raj PA, Antonyraj KJ, Karuna S, Karan T (2000) Large-scale synthesis and functional elements for the antimicrobial activity of defensins. Biochem J 347:633–641Google Scholar
  78. 78.
    Oren Z, Shai Y (1997) Selective lysis of bacteria but not mammalian cells by diastereomers of melittin: structure-function study. Biochemistry 36:1826–1835Google Scholar
  79. 79.
    Hancock REW, Diamond G (2000) The role of cationic antimicrobial peptides in innate host defenses. Trends Microbiol 8:402–410CrossRefPubMedGoogle Scholar
  80. 80.
    Shimoda M, Ohki K, Shimamoto Y, Kohashi O (1995) Morphology of defensin-treated Staphylococcus aureus. Infect Immun 63:2886–2891Google Scholar
  81. 81.
    Oren Z, Shai Y (1996) A class of highly potent antibacterial peptides derived from pardaxin, a pore-forming peptide isolated from Moses sole fish Pardachirus marmoratus. Eur J Biochem 237:303–310Google Scholar
  82. 82.
    Chan SC, Yau WL, Wang W, Smith DK, Sheu FS, Chen HM (1998) Microscopic observations of the different morphological changes caused by anti-bacterial peptides on Klebsiella pneumoniae and HL-60 leukemia cells. J Pept Sci 4:413–425Google Scholar
  83. 83.
    Matsuzaki K, Shioyama T, Okamura E, Umemura J, Takenaka T, Takaishi Y, Fujita T, Miyajima K (1991) A comparative study on interactions of alpha-aminoisobutyric acid containing antibiotic peptides, trichopolyn I and hypelcin A with phosphatidylcholine bilayers. Biochim Biophys Acta 1070:419–428Google Scholar
  84. 84.
    Sieprawska-Lupa M, Mydel P, Krawczyk K, Wojcik K, Puklo M, Lupa B, Suder P, Silberring J, Reed M, Pohl J, Shafer W, McAleese F, Foster T, Travis J, Potempa J (2004) Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother 48:4673–4679Google Scholar
  85. 85.
    Campos MA, Vargas MA, Regueiro V, Llompart CM, Alberti S, Bengoechea JA (2004) Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides. Infect Immun 72:7107–7114Google Scholar
  86. 86.
    Fedtke I, Gotz F, Peschel A (2004) Bacterial evasion of innate host defenses—the Staphylococcus aureus lesson. Int J Med Microbiol 294:189–194Google Scholar
  87. 87.
    Yang D, Chertov O, Oppenheim JJ (2001) Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37). J Leukoc Biol 69:691–697Google Scholar
  88. 88.
    Yang D, Chertov O, Oppenheim JJ (2001) The role of mammalian antimicrobial peptides and proteins in awakening of innate host defenses and adaptive immunity. Cell Mol Life Sci 58:978–989Google Scholar
  89. 89.
    Biragyn A, Surenhu M, Yang D, Ruffini PA, Haines BA, Klyushnenkova E, Oppenheim JJ, Kwak LW (2001) Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens. J Immunol 167:6644–6653Google Scholar
  90. 90.
    Hancock REW (2000) Cationic antimicrobial peptides: towards clinical applications. Expert Opin Investig Drugs 9:1723–1729Google Scholar
  91. 91.
    Hancock REW (1999) Host defense (cationic) peptides: what is their future clinical potential? Drugs 57:469–473Google Scholar
  92. 92.
    De Lucca AJ, Bland JM, Grimm C, Jacks TJ, Cary JW, Jaynes JM, Cleveland TE, Walsh TJ (1998) Fungicidal properties, sterol binding, and proteolytic resistance of the synthetic peptide D4E1. Can J Microbiol 44:514–520Google Scholar
  93. 93.
    Maloy WL, Kari UP (1995) Structure-activity studies on magainins and other host defense peptides. Biopolymers 37:105–122Google Scholar
  94. 94.
    Cirioni O, Giacometti A, Ghiselli R, Mocchegiani F, Fineo A, Orlando F, Del Prete MS, Rocci M, Saba V, Scalise G (2002) Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model. Antimicrob Agents Chemother 46:101–104Google Scholar
  95. 95.
    Chen J, Falla TJ, Liu H, Hurst MA, Fujii CA, Mosca DA, Embree JR, Loury DJ, Radel PA, Cheng Chang C, Gu L, Fiddes JC (2000) Development of protegrins for the treatment and prevention of oral mucositis: structure-activity relationships of synthetic protegrin analogues. Biopolymers 55:88–98Google Scholar
  96. 96.
    Osusky M, Zhou G, Osuska L, Hancock RE, Kay WW, Misra S (2000) Transgenic plants expressing cationic peptide chimeras exhibit broad-spectrum resistance to phytopathogens. Nat Biotechnol 18:1162–1166CrossRefPubMedGoogle Scholar
  97. 97.
    Hancock REW, Lehrer R (1998) Cationic peptides: a new source of antibiotics. Trends Biotechnol 16:82–88Google Scholar
  98. 98.
    Simon C, Stille W (2000) Antibiotika-Therapie in Klinik und Praxis. Schattauer, Stuttgart, pp 205–212Google Scholar
  99. 99.
    Peschel A (2002) How do bacteria resist human antimicrobial peptides? Trends Microbiol 10:179–186Google Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • Josef Johann Schneider
    • 1
  • Angela Unholzer
    • 1
  • Martin Schaller
    • 1
  • Monika Schäfer-Korting
    • 2
  • Hans Christian Korting
    • 1
  1. 1.Klinik und Poliklinik für Dermatologie und AllergologieLudwig-Maximilians-Universität MünchenMunichGermany
  2. 2.Institut für PharmazieFreie UniversitätBerlinGermany

Personalised recommendations